Acquisition by Kevin Conroy of 2489 shares of EXACT Sciences subject to Rule 16b-3
| EXAS Stock | USD 56.84 0.00 0.00% |
Slightly above 76 percent of EXACT Sciences' private investors are selling. The analysis of the overall investor sentiment regarding EXACT Sciences suggests that a fairly large number of traders are terrified. EXACT Sciences' investing sentiment can be driven by a variety of factors including economic data, EXACT Sciences' earnings reports, geopolitical events, and overall market trends.
EXACT |
Filed transaction by EXACT Sciences Director, Officer: President And Ceo. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
EXACT Sciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards EXACT Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
EXACT Sciences Fundamental Analysis
We analyze EXACT Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
EXACT Sciences is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
EXACT Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EXACT Sciences stock to make a market-neutral strategy. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with similar companies.
Peers
EXACT Sciences Related Equities
| A | Agilent Technologies | 0.15 | ||||
| TMO | Thermo Fisher | 0.08 | ||||
| CRL | Charles River | 0.00 | ||||
| ILMN | Illumina | 0.00 | ||||
| MYGN | Myriad Genetics | 0.38 | ||||
| DHR | Danaher | 3.14 | ||||
| CSTL | Castle Biosciences | 3.20 | ||||
| NTRA | Natera | 5.70 | ||||
| CDNA | Caredx | 6.87 | ||||
| TWST | Twist Bioscience | 9.96 | ||||
| GH | Guardant Health | 10.68 |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.